V/Q System for Acute Respiratory Distress Syndrome in COVID-19
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a special Vest that helps COVID-19 patients with severe lung issues breathe better. The Vest inflates and deflates to improve oxygen levels in the blood. It aims to provide a safer and simpler alternative to turning patients onto their stomachs.
Who Is on the Research Team?
Maxwell Weinmann, MD
Principal Investigator
Emory University
Are You a Good Fit for This Trial?
This trial is for patients with severe breathing problems due to ARDS from COVID-19, who are on ventilators. They must have a specific oxygenation measurement (PaO2/FiO2 < 300) and consent from a legal representative. It's not for those with recent chest trauma, high brain pressure, certain esophageal conditions, pre-existing lung issues like pulmonary hypertension or fibrosis, skin wounds affected by the Vest device, severe scoliosis, extreme obesity (BMI >37), pregnant women or if they can't maintain an oxygen saturation above 88%.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo therapy with the V/Q System for up to 4 hours
Post-intervention Observation
Participants are observed for 1 hour following the intervention to monitor changes in arterial oxygenation levels
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- V/Q System
Find a Clinic Near You
Who Is Running the Clinical Trial?
Emory University
Lead Sponsor
Georgia Tech Research Foundation
Collaborator
Georgia Clinical & Translational Science Alliance
Collaborator